NFKB1 and chronic kidney disease: Ultimately, our study demonstrated that PCA might enhance its anti‐inflammatory and antioxidant capacities and reduce protein degradation by inhibiting the TLR4/MyD88/NF‐κB signalling pathway, thereby alleviating muscle wasting in CKD rats.